BlackRock’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53M Sell
16,826,695
-230,183
-1% -$362K ﹤0.01% 3788
2025
Q4
$52.9M Buy
17,056,878
+3,210,824
+23% +$9.16M ﹤0.01% 2477
2025
Q3
$36.4M Buy
13,846,054
+1,703,458
+14% +$3.75M ﹤0.01% 2714
2025
Q2
$14.9M Buy
12,142,596
+9,069,823
+295% +$9.89M ﹤0.01% 3184
2025
Q1
$3.38M Buy
3,072,773
+43,564
+1% +$50.4K ﹤0.01% 3801
2024
Q4
$2.74M Buy
3,029,209
+223,567
+8% +$192K ﹤0.01% 3947
2024
Q3
$2.77M Sell
2,805,642
-5,865
-0.2% -$5.64K ﹤0.01% 3901
2024
Q2
$2.53M Sell
2,811,507
-277,819
-9% -$208K ﹤0.01% 3900
2024
Q1
$3.65M Sell
3,089,326
-289,320
-9% -$318K ﹤0.01% 3804
2023
Q4
$3.08M Sell
3,378,646
-1,088,007
-24% -$804K ﹤0.01% 3879
2023
Q3
$3.72M Buy
4,466,653
+2,554,648
+134% +$2.94M ﹤0.01% 3784
2023
Q2
$2.29M Sell
1,912,005
-2,881,674
-60% -$3.59M ﹤0.01% 3999
2023
Q1
$6.04M Sell
4,793,679
-619,344
-11% -$1.19M ﹤0.01% 3552
2022
Q4
$11.7M Sell
5,413,023
-95,154
-2% -$783K ﹤0.01% 3322
2022
Q3
$66M Buy
5,508,177
+342,213
+7% +$4.25M ﹤0.01% 2245
2022
Q2
$43.2M Sell
5,165,964
-163,167
-3% -$1.26M ﹤0.01% 2584
2022
Q1
$46.3M Sell
5,329,131
-100,555
-2% -$970K ﹤0.01% 2638
2021
Q4
$61.4M Buy
5,429,686
+66,816
+1% +$794K ﹤0.01% 2520
2021
Q3
$67.4M Sell
5,362,870
-52,935
-1% -$487K ﹤0.01% 2462
2021
Q2
$44M Buy
5,415,805
+50,456
+0.9% +$437K ﹤0.01% 2788
2021
Q1
$49.6M Buy
5,365,349
+663,314
+14% +$6.69M ﹤0.01% 2615
2020
Q4
$45.5M Buy
4,702,035
+62,411
+1% +$615K ﹤0.01% 2535
2020
Q3
$57.6M Buy
4,639,624
+344,508
+8% +$4.57M ﹤0.01% 2207
2020
Q2
$55.8M Buy
4,295,116
+788,180
+22% +$9.91M ﹤0.01% 2185
2020
Q1
$35.6M Sell
3,506,936
-39,584
-1% -$517K ﹤0.01% 2276
2019
Q4
$55.4M Buy
3,546,520
+743,721
+27% +$15M ﹤0.01% 2302
2019
Q3
$47.1M Buy
2,802,799
+1,507,575
+116% +$30M ﹤0.01% 2324
2019
Q2
$28.7M Buy
1,295,224
+500,944
+63% +$9.58M ﹤0.01% 2644
2019
Q1
$17.2M Buy
+794,280
New +$16.6M ﹤0.01% 2824

Other funds holding GOSS